Literature DB >> 24778396

Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?

Mark J Brenner1, Irving D Kaplan2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24778396      PMCID： PMC4039871          DOI： 10.1200/JCO.2013.54.4247

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Prostate cancer and the hypofractionation hypothesis.

Authors:  W Robert Lee
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

2.  Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  Alan Pollack; Gail Walker; Eric M Horwitz; Robert Price; Steven Feigenberg; Andre A Konski; Radka Stoyanova; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; Charlie Ma; Mark K Buyyounouski
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

3.  Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years.

Authors:  Alan J Katz; Michael Santoro; Fred Diblasio; Richard Ashley
Journal:  Radiat Oncol       Date:  2013-05-13       Impact factor: 3.481
  3 in total
  2 in total

1.  Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost.

Authors:  Philip S Boonstra; Jeremy M G Taylor; Beata Smolska-Ciszewska; Katarzyna Behrendt; Tomasz Dworzecki; Marzena Gawkowska-Suwinska; Brygida Bialas; Rafal Suwinski
Journal:  Br J Radiol       Date:  2016-02-23       Impact factor: 3.039

Review 2.  Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Authors:  Ben G L Vanneste; Evert J Van Limbergen; Emile N van Lin; Joep G H van Roermund; Philippe Lambin
Journal:  Biomed Res Int       Date:  2016-12-28       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.